Reproducibility and comparison of responses to inhaled histamine and methacholine. 1978

E F Juniper, and P A Frith, and C Dunnett, and D W Cockcroft, and F E Hargreave

The efficiency of a standardised inhalation test procedure was studied by examining the reproducibility of responses to histamine and methacholine. In addition, the responses to the two agents were compared. Each set of duplicate tests was carried out on a separate day within one week, and all factors known or presumed to influence responses were carefully controlled. The results were expressed as the provocative concentration of the agent causing a 20% fall in forced expired volume in one second (PC20). Responses to histamine and methacholine were highly reproducible (coefficients of determination [r2] = 0.994 and 0.990 respectively). Responsiveness to histamine correlated closely with responsiveness to methacholine (r2 = 0.85). There was a small but significant cumulative dose effect with methacholine (P less than 0.01) but not with histamine. Side effects of throat irritation, flushing, and headache were more frequent with histamine than methacholine, and were dose-related. The high level of reproducibility indicates the efficiency of the test procedure. The similar severity of effects by agents with different mechanisms of action suggests that the primary cause of non-specific bronchial hyperreactivity lies at the level of bronchial smooth muscle.

UI MeSH Term Description Entries
D008688 Methacholine Compounds A group of compounds that are derivatives of beta-methylacetylcholine (methacholine). Compounds, Methacholine
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

E F Juniper, and P A Frith, and C Dunnett, and D W Cockcroft, and F E Hargreave
July 1983, The Tohoku journal of experimental medicine,
E F Juniper, and P A Frith, and C Dunnett, and D W Cockcroft, and F E Hargreave
April 1983, The Journal of allergy and clinical immunology,
E F Juniper, and P A Frith, and C Dunnett, and D W Cockcroft, and F E Hargreave
June 1997, Respirology (Carlton, Vic.),
E F Juniper, and P A Frith, and C Dunnett, and D W Cockcroft, and F E Hargreave
September 1991, Journal of applied physiology (Bethesda, Md. : 1985),
E F Juniper, and P A Frith, and C Dunnett, and D W Cockcroft, and F E Hargreave
December 1984, Chest,
E F Juniper, and P A Frith, and C Dunnett, and D W Cockcroft, and F E Hargreave
October 1991, Chest,
E F Juniper, and P A Frith, and C Dunnett, and D W Cockcroft, and F E Hargreave
March 1987, Journal of applied physiology (Bethesda, Md. : 1985),
E F Juniper, and P A Frith, and C Dunnett, and D W Cockcroft, and F E Hargreave
August 1984, The American review of respiratory disease,
E F Juniper, and P A Frith, and C Dunnett, and D W Cockcroft, and F E Hargreave
March 1983, Journal of applied physiology: respiratory, environmental and exercise physiology,
E F Juniper, and P A Frith, and C Dunnett, and D W Cockcroft, and F E Hargreave
July 1994, American journal of respiratory and critical care medicine,
Copied contents to your clipboard!